Advances in targeting cyclic nucleotide phosphodiesterases

DH Maurice, H Ke, F Ahmad, Y Wang… - Nature reviews Drug …, 2014 - nature.com
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and
cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides …

[HTML][HTML] Genetics and molecular pathogenesis of gastric adenocarcinoma

P Tan, KG Yeoh - Gastroenterology, 2015 - Elsevier
Gastric cancer (GC) is globally the fifth most common cancer and third leading cause of
cancer death. A complex disease arising from the interaction of environmental and host …

Genomic and molecular characterization of esophageal squamous cell carcinoma

DC Lin, JJ Hao, Y Nagata, L Xu, L Shang, X Meng… - Nature …, 2014 - nature.com
Esophageal squamous cell carcinoma (ESCC) is prevalent worldwide and particularly
common in certain regions of Asia. Here we report the whole-exome or targeted deep …

[HTML][HTML] Encoding and decoding cellular information through signaling dynamics

JE Purvis, G Lahav - Cell, 2013 - cell.com
A growing number of studies are revealing that cells can send and receive information by
controlling the temporal behavior (dynamics) of their signaling molecules. In this Review, we …

Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability

K Akagi, J Li, TR Broutian, H Padilla-Nash… - Genome …, 2014 - genome.cshlp.org
Genomic instability is a hallmark of human cancers, including the 5% caused by human
papillomavirus (HPV). Here we report a striking association between HPV integration and …

MITF in melanoma: mechanisms behind its expression and activity

ML Hartman, M Czyz - Cellular and Molecular Life Sciences, 2015 - Springer
MITF (microphthalmia-associated transcription factor) represents a melanocytic lineage-
specific transcription factor whose role is profoundly extended in malignant melanoma. Over …

The genomic landscape of nasopharyngeal carcinoma

DC Lin, X Meng, M Hazawa, Y Nagata, AM Varela… - Nature …, 2014 - nature.com
Nasopharyngeal carcinoma (NPC) has extremely skewed ethnic and geographic
distributions, is poorly understood at the genetic level and is in need of effective therapeutic …

Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders

A Bhat, B Ray, AM Mahalakshmi, S Tuladhar… - Pharmacological …, 2020 - Elsevier
Phosphodiesterases (PDE) are a diverse family of enzymes (11 isoforms so far identified)
responsible for the degradation of cyclic adenosine monophosphate (cAMP) and cyclic …

Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets

F Ahmad, T Murata, K Shimizu, E Degerman… - Oral …, 2015 - Wiley Online Library
By catalyzing hydrolysis of cyclic adenosine monophosphate (cAMP) and cyclic guanosine
monophosphate (cGMP), cyclic nucleotide phosphodiesterases are critical regulators of their …

Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis

B Ye, D Fan, W Xiong, M Li, J Yuan, Q Jiang… - Nature …, 2021 - nature.com
The role of cis-elements and their aberrations remains unclear in esophageal squamous cell
carcinoma (ESCC, further abbreviated EC). Here we survey 28 H3K27ac-marked active …